Literature DB >> 9081619

Open channel block by physostigmine and procaine in embryonic-like nicotinic receptors of mouse muscle.

J Bufler1, C Franke, H Parnas, J Dudel.   

Abstract

Embryonic-like nicotinic channels were studied in mouse myotubes. Channel currents were measured by patch-clamping outside-out excised patches to which pulses of agonists and drugs could be applied by a liquid filament switch. The holding potential of the patches was generally around 40 mV. Pulses of 10(-4) M acetylcholine elicited average channel currents which reached a peak open probability, P(o,peak,) of 0.93 within 0.5 ms and decayed with a time constant of desensitization of 20-80 ms. When physostigmine (10(-5) to 10(-3) M) or procaine (3 x 10(-5) to 10(-3) M) was added to the acetylcholine pulses, a fast decay component of the current appeared which shortened to a time constant of 0.5 ms for the maximal drug concentrations. The fast decay was followed by a slow one which declined in amplitude with increasing concentrations of the drugs. After the end of pulses of 10 M acetylcholine plus 3 x 10(-4) M physostigmine the average current rose again, reaching a peak with approximately 5 ms delay, and then decayed slowly. The amplitude of this recovery current was approximately 0.4 P(o,peak) after 5 ms pulses and decreased with increasing pulse duration due to desensitization. The results can be quantitatively modelled based on a circular reaction scheme involving desensitization. Physostigmine and procaine bind to the open state to cause channel block. Also, the blocked channel was subject to desensitization. The rate constants of block were 6 x 10(6) M(-1) s(-1) for physostigmine and 2 x 10(6) M(-1) s(-1) for procaine, and the rate of unblocking was 200 s(-1) for both blockers (at -40 mV and 20 degrees C).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9081619     DOI: 10.1111/j.1460-9568.1996.tb01253.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Kinetic analysis of recombinant mammalian alpha(1) and alpha(1)beta glycine receptor channels.

Authors:  B Mohammadi; K Krampfl; C Cetinkaya; H Moschref; J Grosskreutz; R Dengler; J Bufler
Journal:  Eur Biophys J       Date:  2003-02-19       Impact factor: 1.733

2.  Short openings in high resolution single channel recordings of mouse nicotinic receptors.

Authors:  Stefan Hallermann; Sabine Heckmann; Josef Dudel; Manfred Heckmann
Journal:  J Physiol       Date:  2005-01-27       Impact factor: 5.182

3.  Two mechanisms of action of the adamantane derivative IEM-1460 at human AMPA-type glutamate receptors.

Authors:  Friedrich Schlesinger; Derk Tammena; Klaus Krampfl; Johannes Bufler
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  Molecular mechanisms of interaction between the neuroprotective substance riluzole and GABA(A)-receptors.

Authors:  K Jahn; F Schlesinger; L J Jin; R Dengler; J Bufler; K Krampfl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

5.  Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)-tubocurarine.

Authors:  J Bufler; R Wilhelm; H Parnas; C Franke; J Dudel
Journal:  J Physiol       Date:  1996-08-15       Impact factor: 5.182

6.  Kinetics of desensitization and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells.

Authors:  Kewei D Yu; Qiang Liu; Jie Wu; Ronald J Lukas
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

7.  Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies.

Authors:  Julius Militante; Bei-Wen Ma; Gustav Akk; Joe Henry Steinbach
Journal:  Mol Pharmacol       Date:  2008-06-03       Impact factor: 4.436

8.  α-Conotoxin M1 (CTx) blocks αδ binding sites of adult nicotinic receptors while ACh binding at αε sites elicits only small and short quantal synaptic currents.

Authors:  Josef Dudel
Journal:  Physiol Rep       Date:  2014-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.